Long-term survival analysis of the randomized phase II trial investigating the addition of carboplatin to neoadjuvant therapy for triple-negative (TNBC) and HER2-positive early breast cancer (GeparSixto) - Untch, M.; Schneeweiss, A.; Salat, C.; Rezai, M.; Zahm, D-M.; Klare, P.; Blohmer, J-U.; Tesch, H.; Khandan, F.; Fasching, Peter; Jackisch, C.; Nekljudova, V.; et al. (2017)
EVALuna2:36186